Advisory Committee on the Safety of Vaccines (ACSOV)

7 October 2016

Role of the ACSOV

The Advisory Committee on the Safety of Vaccines is established under Part 6 Division 1EB of the Therapeutic Goods Regulations 1990 (the regulations) to advise and make recommendations to the Minister for Health and the Therapeutic Goods Administration (TGA) on the safety, risk assessment and risk management of vaccines.

ACSOV members


Professor Emily Banks is a public health physician and epidemiologist with interest and expertise in large scale cohort studies, pharmacoepidemiology, women's health, Aboriginal Health and healthy ageing. She is currently the Head of Chronic Disease Epidemiology at the National Centre for Epidemiology and Population Health, Scientific Director of the 45 and Up Study and Chair of both, the Advisory Committee on the Safety of Medicines and the Advisory Committee on the Safety of Vaccines. In 2000 she was awarded the UK National Woman of Achievement in Science and Technology and in 2014 she was awarded the National Breast Cancer Foundation's Patron's Award. She has Served as an advisor to the World Health Organization, and the International Agency for Research on Cancer. The main emphasis of her work has been in using cohort study methodology to identify potentially modifiable factors affecting individual and population health in different settings and in quantifying their effects, to inform improvements in health and health care. Professor Banks provides expertise in epidemiology.


  • Ms Karen Booth is a registered nurse and NSW accredited immuniser and currently the president of the Australian Primary Health Care Nurse Association. Ms Booth holds several committee and advisory group positions including the General Practice Roundtable, the National Immunisation Committee and the Primary Health Care Advisory Group. Ms Booth was also a member of the adhoc working group for the safety of influenza vaccine. Ms Booth provides expertise in the field of immunisation treatment by a nurse.
  • Ms Hazel Clothier is an epidemiologist with special interest in vaccine safety, infectious disease surveillance and outbreak investigation, and is currently the Surveillance Manager with SAEFVIC Victoria. Ms Clothier is also editor of the Victorian Infectious Diseases Bulletin, and a senior lecturer at Melbourne University, where she is the coordinator for the Infectious Disease Epidemiology Unit. Ms Clothier provides expertise in the field of epidemiology.
  • Associate Professor Kristine Macartney is a paediatric infectious disease specialist at The Children's Hospital at Westmead, Deputy Director at the National Centre for Immunisation Research & Surveillance, and an Associate Professor in the Discipline of Paediatrics and Child Health, University of Sydney. She is a Senior Editor of the Australian Immunisation Handbook and a former member of the Advisory Committee on the Safety of Medicines. Associate Professor Macartney provides expertise in the fields of immunology and infectious diseases in children.
  • Dr Nicole Pratt is a senior research fellow at the Quality Use of Medicines and Pharmacy Research Centre of the Sansom Institute at the University of South Australia. She is a member of the Australian Medicines Utilisation Research Australia Committee, a co-coordinator and co-Chair Elect of the Asian Pharmacoepidemiology Network, and a member of the Drug Utilisation Special Interest Group of the International Society for Pharmacoepidemiology. Dr Pratt is a biostatistician and an active researcher in the area of medicine safety. Dr Pratt provides expertise in the field of biostatistics.

ACSOV meetings

ACSOV planned meeting dates 2016
Meeting no. Meeting date
10 3 February 2016
11 8 April 2016
12 12 August 2016
13 9 December 2016

Contacting the ACSOV

To contact the ACSOV Secretariat:

ACSOV Secretariat contact details
Phone +61 2 6232 8734
Fax +61 2 6203 1250
Postal address Advisory Committee on the Safety of Vaccines
Therapeutic Goods Administration
PO Box 100
Woden ACT 2606

Reporting an adverse event following immunisation to the Therapeutic Goods Administration